Our previous studies have illustrated the health benefits of the microbiota-modulating agent – GpS, in both normal and cancer-prone mouse models.26,27,29 One of the beneficial effects of GpS is its effectiveness in suppressing potential harmful bacteria, such as sulfur-reducing bacteria and promoting the SCFA-producing bacteria. Here, NBEAL2 is linked to cancer.